Log in to save to my catalogue

Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in tw...

Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in tw...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_991903b440ee40b4878665ed435d7f4c

Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children

About this item

Full title

Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children

Publisher

London: BioMed Central

Journal title

Pediatric Rheumatology, 2020-06, Vol.18 (1), p.1-51, Article 51

Language

English

Formats

Publication information

Publisher

London: BioMed Central

More information

Scope and Contents

Contents

Background Recurrent pericarditis (RP) is a complication (15–30%) of acute pericarditis with an unknown etiology. Treatment regimen consists of a combination of non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, with the addition of corticosteroids in resistant or intolerant cases. In the last decade anakinra was shown as an effective t...

Alternative Titles

Full title

Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_991903b440ee40b4878665ed435d7f4c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_991903b440ee40b4878665ed435d7f4c

Other Identifiers

ISSN

1546-0096

E-ISSN

1546-0096

DOI

10.1186/s12969-020-00438-5

How to access this item